Evidence map›Paper›PMID 31323313›Full record

ArticleFree radical biology & medicine2019

Unraveling the effects of peroxiredoxin 2 nitration; role of C-terminal tyrosine 193.

Lía M Randall, Joaquín Dalla Rizza, Derek Parsonage, Javier Santos, Ryan A Mehl, W Todd Lowther, Leslie B Poole, Ana Denicola

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Nitration in cancer signaling.Redox biology · 2026
    Review
  2. Article
  3. Review
  4. Peroxiredoxin-2 recycling is slower in denser and pediatric sickle cell red cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Lía M RandallLaboratorio I+D de Moléculas Bioactivas, CENUR Litoral Norte, Universidad de la República, Paysandú, Uruguay; Laboratorio de Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay; Centro de Investigaciones Biomédicas, Universidad de la República, Uruguay.
Joaquín Dalla RizzaLaboratorio de Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay; Centro de Investigaciones Biomédicas, Universidad de la República, Uruguay.
Derek ParsonageDepartment of Biochemistry and Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Javier SantosDepartamento de Fisiología y Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET), Buenos Aires, Argentina.
Ryan A MehlDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, USA.
W Todd LowtherDepartment of Biochemistry and Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Leslie B PooleDepartment of Biochemistry and Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: lbp@csb.wfu.edu.
Ana DenicolaLaboratorio de Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay; Centro de Investigaciones Biomédicas, Universidad de la República, Uruguay. Electronic address: denicola@fcien.edu.uy.
Universidad de la República · UYWake Forest University · USConsejo Nacional de Investigaciones Científicas y Técnicas · AROregon State University · US

Funding

Equipment supplement: Defining Roles Of NitroTyrosine In Disease Via Genetic Code ExpansionR01GM114653 · NIGMS · OREGON STATE UNIVERSITY · PI MEHL, RYAN A · 2015 to 2024
$2.6M
Mechanisms and Regulation of PeroxiredoxinsR01GM119227 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI POOLE, LESLIE B · 2016 to 2019
$1.4M
Development of an improved core technology for efficient genetic code expansion in biomedical researchR01GM131168 · NIGMS · OREGON STATE UNIVERSITY · PI MEHL, RYAN A · 2019 to 2021
$1.1M
NIGMS NIH HHS R01 GM114653NIGMS NIH HHS R01 GM119227NIGMS NIH HHS R01 GM131168
6 · The paper itself

Abstract

Peroxiredoxins (Prx) are enzymes that efficiently reduce hydroperoxides through active participation of cysteine residues (C

Indexed as

Oxidation-ReductionCatalytic DomainCysteineDisulfidesHumansMutationNitratesPeroxidasePeroxidesPeroxiredoxinsPeroxynitrous AcidProtein Processing, Post-TranslationalSignal TransductionTyrosineCysteineDisulfidesNitratesPeroxidasePeroxidesPeroxiredoxinsPeroxynitrous AcidTyrosineHydrogen peroxideHyperoxidationOxidative stressPeroxiredoxinPeroxynitritePost‐translational modification (PTM)Redox signalingTyrosine nitration

Identifiers

PMID31323313
PMCPMC6749834
OpenAlexW2959338423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.